Millennium, Abgenix In Antibody Alliance.

From: Chemical Market Reporter | Date: March 13, 2000 | Copyright information

MILLENNIUM PHARMACEUTICALS Inc. iS expanding its relationship with Abgenix Inc. to include extensive access to Abgenix's XenoMouse technology for the creation of fully human antibodies. Abgenix will receive an undisclosed upfront payment and potential future payments that could reach $100 million plus royalties on product sales.

...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Biotech big shots court tiny Abgenix
; ...analysts looked closer at Abgenix and what it had to offer...not as much the company Abgenix and its revolutionary technology...By this time next year, Abgenix is likely to be fully absorbed...manufacturing facilities of Abgenix intact. But Abgenix's revolutionary XenoMouse ...
ABGENIX Inc.
; ABGENIX Inc. signed a research collaboration, option and license agreement with Amgen Inc. under which Abgenix will generate for Amgen fully human monoclonal antibodies to an undisclosed antigen using its XenoMouse technology.
Abgenix to Solely Own XenoMouse Technology.
; ABGENIX INC. is acquiring all of the interest in the technology owned by JT America Inc., making Abgenix the sole owner of XenoMouse, a leading technology for generating fully human...are useful in treating a wide range of diseases. Abgenix will pay $47 million to JT America for its 50 ...
Continued collaboration
; Pfizer and Abgenix finalized a two-year extension...the extended agreement, Abgenix will use its XenoMouse technology to generate fully human...through the collaboration. Abgenix will receive a fee to...the option to license XenoMouse technology far up to three antigen...an ...
Abgenix and Pfizer Add Second Antigen Target.(Pfizer Inc. and Abgenix Inc. announce a second antigen target )(Business Brief)(Product Announcement)
; ...partner of Fremont, Calif-based Abgenix Inc., will develop a second antigen target using Abgenix's XenoMouse technology. Under the agreement between the companies, Abgenix will use its technology to generate...developed through the collaboration. Abgenix will receive potential ...
Abgenix Buys ImmGenics for $77MM.(Brief Article)
; ...position in antibodies, Abgenix Inc. has agreed to acquire...transaction for $77 million. Abgenix is a biopharmaceutical company...therapies. The company developed XenoMouse technology to enable the rapid generation...ImmGenics acquisition provides Abgenix with screening ...
HUMAN GENOME SCIENCES (HGS) Inc.
; ...SCIENCES (HGS) Inc. has formed research collaboration with Abgenix to develop antibody-based therapeutics. As part of the deal, Abgenix will use its XenoMouse technology to produce fully human antibodies against drug targets discovered by HGS. Abgenix also formed a similar deal with Chiron ...
Demand to expand.
; ...purchase of its smaller partner, Abgenix Inc. in Fremont, could be...full possession of the drug. Abgenix shareholders are scheduled...also would gain control over Abgenix's Xenomouse technology, which creates monoclonal...for fighting osteoporosis. Abgenix would be owed royalties ...
Amgen acquisition faces suit.
; ...Allison Bruce Dec. 24--A shareholder of Abgenix Inc. has filed a lawsuit in California...Alameda County to halt the acquisition of Abgenix by Amgen Inc. The lawsuit, filed on behalf of one Abgenix stockholder and seeking status as a class-acti...
Abgenix, to be acquired by Amgen, posts a loss.
; ...billion, or $22.50 in cash for each outstanding Abgenix share. That was a 54 percent premium over Abgenix's stock price at the time of the offer. The total...assumption of debt, comes to about $2.7 billion. Abgenix's shares closed at $22.16 Tuesday. The company...The acquisition has received antitrust ...